These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A Novel Approach to Safer Glucocorticoid Receptor-Targeted Anti-lymphoma Therapy via REDD1 (Regulated in Development and DNA Damage 1) Inhibition. Lesovaya EA; Savinkova AV; Morozova OV; Lylova ES; Zhidkova EM; Kulikov EP; Kirsanov KI; Klopot A; Baida G; Yakubovskaya MG; Gordon LI; Readhead B; Dudley JT; Budunova I Mol Cancer Ther; 2020 Sep; 19(9):1898-1908. PubMed ID: 32546661 [TBL] [Abstract][Full Text] [Related]
3. REDD1 (regulated in development and DNA damage 1) modulates the glucocorticoid receptor function in keratinocytes. Chudakova DA; Trubetskoy D; Baida G; Bhalla P; Readhead B; Budunova I Exp Dermatol; 2023 Oct; 32(10):1725-1733. PubMed ID: 37483165 [TBL] [Abstract][Full Text] [Related]
5. The long winding road to the safer glucocorticoid receptor (GR) targeting therapies. Lesovaya EA; Chudakova D; Baida G; Zhidkova EM; Kirsanov KI; Yakubovskaya MG; Budunova IV Oncotarget; 2022; 13():408-424. PubMed ID: 35198100 [TBL] [Abstract][Full Text] [Related]
6. REDD1 functions at the crossroads between the therapeutic and adverse effects of topical glucocorticoids. Baida G; Bhalla P; Kirsanov K; Lesovaya E; Yakubovskaya M; Yuen K; Guo S; Lavker RM; Readhead B; Dudley JT; Budunova I EMBO Mol Med; 2015 Jan; 7(1):42-58. PubMed ID: 25504525 [TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid Receptor Counteracts Tumorigenic Activity of Akt in Skin through Interference with the Phosphatidylinositol 3-Kinase Signaling Pathway. Leis H; Page A; Ramírez A; Bravo A; Segrelles C; Paramio J; Barettino D; Jorcano JL; Pérez P Mol Endocrinol; 2004 Feb; 18(2):303-11. PubMed ID: 14615607 [TBL] [Abstract][Full Text] [Related]
8. Sexual dimorphism in atrophic effects of topical glucocorticoids is driven by differential regulation of atrophogene REDD1 in male and female skin. Baida G; Agarwal S; Readhead B; Dudley JT; Budunova I Oncotarget; 2020 Jan; 11(4):409-418. PubMed ID: 32064044 [TBL] [Abstract][Full Text] [Related]
10. Reversion of glucocorticoid-induced senescence and collagen synthesis decrease by LY294002 is mediated through p38 in skin. Le QV; Wen SY; Chen CJ; Huang CY; Kuo WW Int J Biol Sci; 2022; 18(16):6102-6113. PubMed ID: 36439879 [TBL] [Abstract][Full Text] [Related]
11. LY294002 inhibits glucocorticoid-induced COX-2 gene expression in cardiomyocytes through a phosphatidylinositol 3 kinase-independent mechanism. Sun H; Xu B; Sheveleva E; Chen QM Toxicol Appl Pharmacol; 2008 Oct; 232(1):25-32. PubMed ID: 18657281 [TBL] [Abstract][Full Text] [Related]
12. Selective Activator of the Glucocorticoid Receptor Compound A Dissociates Therapeutic and Atrophogenic Effects of Glucocorticoid Receptor Signaling in Skin. Klopot A; Baida G; Bhalla P; Haegeman G; Budunova I J Cancer Prev; 2015 Dec; 20(4):250-9. PubMed ID: 26734587 [TBL] [Abstract][Full Text] [Related]
13. Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice. Chamcheu JC; Adhami VM; Esnault S; Sechi M; Siddiqui IA; Satyshur KA; Syed DN; Dodwad SM; Chaves-Rodriquez MI; Longley BJ; Wood GS; Mukhtar H Antioxid Redox Signal; 2017 Jan; 26(2):49-69. PubMed ID: 27393705 [TBL] [Abstract][Full Text] [Related]
15. PI3K/AKT/mTOR pathway inhibitors inhibit the growth of melanoma cells with mTOR H2189Y mutations in vitro. Wu X; Yu J; Yan J; Dai J; Si L; Chi Z; Sheng X; Cui C; Ma M; Tang H; Xu T; Yu H; Kong Y; Guo J Cancer Biol Ther; 2018 Jul; 19(7):584-589. PubMed ID: 29708815 [TBL] [Abstract][Full Text] [Related]
16. IL-12 inhibits glucocorticoid-induced T cell apoptosis by inducing GMEB1 and activating PI3K/Akt pathway. Kawabe K; Lindsay D; Braitch M; Fahey AJ; Showe L; Constantinescu CS Immunobiology; 2012 Jan; 217(1):118-23. PubMed ID: 21840619 [TBL] [Abstract][Full Text] [Related]
17. Targeting PI3K-AKT-mTOR by LY3023414 inhibits human skin squamous cell carcinoma cell growth in vitro and in vivo. Zou Y; Ge M; Wang X Biochem Biophys Res Commun; 2017 Aug; 490(2):385-392. PubMed ID: 28623128 [TBL] [Abstract][Full Text] [Related]
18. Important role of kallikrein 6 for the development of keratinocyte proliferative resistance to topical glucocorticoids. Kishibe M; Baida G; Bhalla P; Lavker RM; Schlosser B; Iinuma S; Yoshida S; Dudley JT; Budunova I Oncotarget; 2016 Oct; 7(43):69479-69488. PubMed ID: 27283773 [TBL] [Abstract][Full Text] [Related]
19. Salvia miltiorrhiza stems and leaves total phenolic acids combination with tanshinone protect against DSS-induced ulcerative colitis through inhibiting TLR4/PI3K/AKT/mTOR signaling pathway in mice. Peng KY; Gu JF; Su SL; Zhu Y; Guo JM; Qian DW; Duan JA J Ethnopharmacol; 2021 Jan; 264():113052. PubMed ID: 32535239 [TBL] [Abstract][Full Text] [Related]
20. Altered REDD1, myostatin, and Akt/mTOR/FoxO/MAPK signaling in streptozotocin-induced diabetic muscle atrophy. Hulmi JJ; Silvennoinen M; Lehti M; Kivelä R; Kainulainen H Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E307-15. PubMed ID: 22068602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]